British journal of clinical practice. Supplement (Br J Clin Pract Suppl)

Journal PubWeight™ 76.51‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study. 1994 2.09
2 Fungal infections in AIDS patients. 1990 1.15
3 Benign screen detected abnormalities of the breast: histopathological features. 1989 1.05
4 Reye's syndrome and aspirin: a review. 1990 1.04
5 Biochemical basis for the activity and selectivity of oral antifungal drugs. 1990 1.03
6 Amiodarone pharmacokinetics. 1986 1.02
7 Hypertension and hyperlipidaemia: garlic helps in mild cases. 1990 1.02
8 The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. 1990 1.01
9 Inhibition of human platelet aggregation by cyclandelate. 1984 0.96
10 Celiprolol: pharmacokinetics and duration of pharmacodynamic activity. 1985 0.95
11 The neuropathology of vigabatrin. 1988 0.93
12 Evoked potential monitoring of vigabatrin patients. 1988 0.91
13 Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. 1984 0.91
14 Oral candidosis in HIV-infected patients. 1990 0.90
15 Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. 1989 0.90
16 The clinical efficacy of Cyclospasmol: a review of the literature. 1984 0.90
17 Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy. 1990 0.89
18 Effect of garlic on conjunctival vessels: a randomised, placebo-controlled, double-blind trial. 1990 0.89
19 CSF soluble proteins and vigabatrin. 1988 0.88
20 Therapy with garlic: results of a placebo-controlled, double-blind study. 1990 0.88
21 The clinical assessment of mastalgia. 1989 0.87
22 Comparative effects of enoximone and nitroglycerin on left ventricular performance and regional wall motion in ischaemic cardiomyopathy. 1988 0.87
23 Hepatic effects of amiodarone. 1986 0.86
24 Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes. 1984 0.86
25 Studies of tamoxifen in women with mastalgia. 1989 0.86
26 Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension. 1987 0.86
27 Pharmacokinetics of oral antifungals and their clinical implications. 1990 0.86
28 Food and fasting intake of sustained release theophylline preparations. 1984 0.84
29 Circadian variation in the absorption of three sustained release theophylline products in asthmatic children and the effect of food on absorption of Somophyllin-CRT. 1984 0.83
30 Influence of garlic powder on cutaneous microcirculation: a randomised, placebo-controlled, double-blind, crossover study in apparently healthy subjects. 1990 0.83
31 A prospective study of nipple discharge. 1989 0.83
32 A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study. 1985 0.82
33 Diagnosis and pathogenesis of dermatophyte infections. 1990 0.82
34 A double-blind comparison of ibuprofen and paracetamol in juvenile pyrexia. 1990 0.82
35 Ibuprofen versus paracetamol for the treatment of fever in children. 1990 0.82
36 Effects of garlic on blood fluidity and fibrinolytic activity: a randomised, placebo-controlled, double-blind study. 1990 0.81
37 Skin manifestations in AIDS patients. 1990 0.81
38 Celiprolol--pharmacological profile of an unconventional beta-blocker. 1985 0.80
39 Oral feeding after uncomplicated abdominal surgery. 1988 0.80
40 Trials, costs and complications. 1988 0.80
41 Fluvastatin in combination with other lipid-lowering agents. 1996 0.80
42 Low-dose danazol for mastalgia. 1989 0.80
43 Diagnostic laboratory techniques in vaginal candidosis. 1990 0.80
44 Bacterial vaginosis. 1990 0.80
45 Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study. 1996 0.80
46 The patient at risk: who should we be treating? 1996 0.80
47 A controlled trial of gamma-vinyl-GABA (vigabatrin) in drug-resistant epilepsy. 1988 0.80
48 The effect of cyclandelate on cholesterol synthesis. 1984 0.80
49 Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase. 1984 0.79
50 Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate. 1984 0.79
Next 50